Riestenberg RA, et al. – Given the increased risk for cardiovascular diseases—including myocardial infarction and stroke—in people with HIV infection (PWH), researchers compared a unique cohort of 5,039 PWH with 10,011 uninfected control individuals in terms of statin types used, achievement of lipid-lowering by statin use, and racial and ethnic disparities in appropriate statin use. Among PWH with statin indication(s), a statin was prescribed less frequently among black and Hispanic people than white individuals. These racial/ethnic disparities were not as pronounced among uninfected people. Among those prescribed statins, PWH were more frequently prescribed pravastatin (34.8% vs 12.3%) or atorvastatin (72.2% vs 65.6%) and less frequently simvastatin (14.2% vs 39.5%) vs control individuals, respectively.